» Articles » PMID: 21362470

Endothelial Nitric Oxide Synthase Uncoupling As a Key Mediator of Melanocyte Malignant Transformation Associated with Sustained Stress Conditions

Overview
Date 2011 Mar 3
PMID 21362470
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Melanoma cell lines and cells corresponding to premalignant melanocytes were established by our group after subjecting a nontumorigenic murine melanocyte lineage, melan-a, to sequential cycles of anchorage blockade. Previous results showed that in melan-a cells the superoxide level increases after such procedure. Superoxide production during melanocyte de-adhesion was inhibited by L-sepiapterin, the precursor of eNOS cofactor BH4, and increased by the inhibitor of BH4 synthesis, DAHP, hence indicating a partial uncoupling state of eNOS. The eNOS uncoupling seems to be maintained in cells derived from melan-a, because they present decreased nitric oxide and increased superoxide levels. The inhibition of superoxide production in Tm5 melanoma cells with L-sepiapterin reinforces their eNOS-uncoupled state. The maintenance of oxidative stress seems to be important in melanoma apoptosis resistance because Mn(III)TBAP, a superoxide scavenger, or L-sepiapterin renders Tm5 cells more sensitive to anoikis and chemotherapy. More importantly, eNOS uncoupling seems to play a pivotal role in melanocyte malignant transformation induced by sustained anchorage impediment, because no malignant transformation was observed when L-NAME-treated melanocytes were subjected to sequential cycles of de-adhesion. Our results show that uncoupled eNOS contributes to superoxide production during melanocyte anchorage impediment, contributing to anoikis resistance and malignant transformation.

Citing Articles

LncRNAs in melanoma phenotypic plasticity: emerging targets for promising therapies.

Beatriz Cristina Biz T, Carolina de Sousa C, Frank John S, Miriam Galvonas J RNA Biol. 2024; 21(1):81-93.

PMID: 39498940 PMC: 11540095. DOI: 10.1080/15476286.2024.2421672.


A metabolic perspective on nitric oxide function in melanoma.

Jimenez J, Dubey P, Carter B, Koomen J, Markowitz J Biochim Biophys Acta Rev Cancer. 2023; 1879(1):189038.

PMID: 38061664 PMC: 11380350. DOI: 10.1016/j.bbcan.2023.189038.


The pigmentation phenotype of melanocytes affects their response to nitric oxide .

Marek L, Tam I, Kurkiewicz S, Dzierzega-Lecznar A Postepy Dermatol Alergol. 2023; 40(1):150-158.

PMID: 36909911 PMC: 9993194. DOI: 10.5114/ada.2022.120130.


Disruption of Redox Homeostasis by Alterations in Nitric Oxide Synthase Activity and Tetrahydrobiopterin along with Melanoma Progression.

Soares J, Goncalves D, de Sousa R, Mouro M, Higa E, Sperandio L Int J Mol Sci. 2022; 23(11).

PMID: 35682659 PMC: 9181279. DOI: 10.3390/ijms23115979.


Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.

Rius F, Papaiz D, Azevedo H, Ayub A, Pessoa D, Oliveira T Clin Epigenetics. 2022; 14(1):68.

PMID: 35606887 PMC: 9128240. DOI: 10.1186/s13148-022-01291-x.